These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis]. Kang WL, Xie YG, Tan WG, Chu NH, Li L, You YH, Yang YZ, Wang XM, Yan XL, Miao ZP, Duanmu HJ. Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883 [Abstract] [Full Text] [Related]
23. [Effects of intermittent short-course chemotherapy under full-course supervision on the treatment of smear positive pulmonary tuberculosis]. Yan S, Ye H, Lin S. Zhonghua Jie He He Hu Xi Za Zhi; 1996 Apr; 19(2):104-6. PubMed ID: 9388851 [Abstract] [Full Text] [Related]
24. [Daily ultrashort chemotherapy and intermittent short-term chemotherapy with 4 drugs of communicable pulmonary tuberculosis treated for the first time. Results of a cooperative multicenter study]. Eule H, Beck H, Evers H, Fischer P, Kwiatkowski H, Merkel S, Reech R, Sieler R, Thomas E, Weinecke W. Z Erkr Atmungsorgane; 1986 Apr; 167(1-2):29-41. PubMed ID: 3532585 [Abstract] [Full Text] [Related]
26. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results]. Fujino T, Hasegawa N, Satou R, Komatsu H, Kawada K. Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579 [Abstract] [Full Text] [Related]
31. [Short course chemotherapy and relapse in pulmonary tuberculosis in Japan]. Kameda K. Kekkaku; 1992 Aug; 67(8):555-63. PubMed ID: 1405185 [Abstract] [Full Text] [Related]
32. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months. Nolan CM, Goldberg SV. Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140 [Abstract] [Full Text] [Related]
33. [Long-term efficacy of full course intermittent short-course chemotherapy on new smear positive tuberculosis patients]. Zhonghua Jie He He Hu Xi Za Zhi; 1997 Jun; 20(3):164-6. PubMed ID: 10072822 [Abstract] [Full Text] [Related]
36. Short-course chemotherapy for paediatric respiratory tuberculosis: 5-year report. Swaminathan S, Raghavan A, Duraipandian M, Kripasankar AS, Ramachandran P. Int J Tuberc Lung Dis; 2005 Jun; 9(6):693-6. PubMed ID: 15971400 [Abstract] [Full Text] [Related]
37. [Effects of two treatment regimens for drug-resistant tuberculosis in tuberculosis control project areas: a comparative study]. Li L, Zheng SH, Chu NH, Xie YG, Yang YZ, Li Q, Wang XM, Yan XL, Tan WG, Miao ZP, Duanmu HJ. Zhonghua Yi Xue Za Zhi; 2008 Dec 30; 88(48):3387-91. PubMed ID: 19159566 [Abstract] [Full Text] [Related]
38. [Effectiveness of short course intermittent regimen on different categories of retreated patients with pulmonary tuberculosis]. Wang X, Dai Y, Cao J. Zhonghua Jie He He Hu Xi Za Zhi; 2001 Aug 30; 24(8):472-6. PubMed ID: 11718037 [Abstract] [Full Text] [Related]
39. Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. Park SK, Kim CT, Song SD. Int J Tuberc Lung Dis; 1998 Nov 30; 2(11):877-84. PubMed ID: 9848607 [Abstract] [Full Text] [Related]
40. Short-course tuberculosis chemotherapy studies conducted in Poland during the past decade. Snider DE, Zierski M, Graczyk J, Bek E, Farer LS. Eur J Respir Dis; 1986 Jan 30; 68(1):12-8. PubMed ID: 3512281 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]